Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 65 (5), 1033-40

Effects of Thiazide-Type and Thiazide-Like Diuretics on Cardiovascular Events and Mortality: Systematic Review and Meta-Analysis


Effects of Thiazide-Type and Thiazide-Like Diuretics on Cardiovascular Events and Mortality: Systematic Review and Meta-Analysis

Rik H G Olde Engberink et al. Hypertension.


Thiazide diuretics are recommended as first-line therapy for hypertension and are among the most commonly prescribed drugs worldwide. According to their molecular structure, thiazide diuretics can be divided in thiazide-type (TT) and thiazide-like (TL) diuretics. TL diuretics have a longer elimination half-life compared with TT diuretics and have been shown to exert additional pharmacological effects, which may differently affect cardiovascular risk. In this meta-analysis, we compared the effects of TT and TL diuretics on cardiovascular events and mortality. Randomized, controlled studies in adult hypertensive patients that compared TT or TL diuretics with placebo or antihypertensive drugs and had ≥1 year follow-up were included. Primary outcome was cardiovascular events; secondary outcomes included coronary events, heart failure, cerebrovascular events, and all-cause mortality. Meta-regression analysis was used to identify confounders and correct for the achieved blood pressure reductions. Twenty-one studies with >480 000 patient-years were included. Outcomes were not affected by heterogeneity in age, sex, and ethnicity among included studies, whereas larger blood pressure reductions were significantly associated with increased risk reductions for all outcomes (P<0.001). Corrected for differences in office blood pressure reductions among trials, TL diuretics resulted in a 12% additional risk reduction for cardiovascular events (P=0.049) and a 21% additional risk reduction for heart failure (P=0.023) when compared with TT diuretics. The incidence of adverse events was comparable among TT, TL diuretics, and other antihypertensive therapy. Our data suggest that the best available evidence seems to favor TL diuretics as the drug of choice when thiazide treatment is considered for hypertension.

Keywords: blood pressure; cardiovascular diseases; diuretics; heart failure; hypertension; thiazides.

Similar articles

  • Treating Essential Hypertension. The First Choice Is Usually a Thiazide Diuretic
    Prescrire Int 23 (152), 215-20. PMID 25325125. - Review
    We concluded in 2004 that the first-choice treatment for hypertension in adults was single-agent therapy with the thiazide diuretic chlortalidone or, when this drug is no …
  • Thiazide and Loop Diuretics
    DA Sica et al. J Clin Hypertens (Greenwich) 13 (9), 639-43. PMID 21896142. - Review
    KEY POINTS AND PRACTICAL RECOMMENDATIONS: • Although chlorthalidone and hydrochlorothiazide are structurally similar, they are very different pharmacokinetically, with ch …
  • Cardioprotective Effect of Thiazide-Like Diuretics: A Meta-Analysis
    P Chen et al. Am J Hypertens 28 (12), 1453-63. PMID 25926533. - Meta-Analysis
    This study suggests that use of TD in hypertensive patients results in a reduction in the risk of CVs. Moreover, thiazide-like diuretics have greater protective effect ag …
  • Goals of Antihypertensive Therapy
    GE McVeigh et al. Drugs 49 (2), 161-75. PMID 7729325. - Review
    Antihypertensive therapy has been used for almost 40 years to reduce blood pressure and to prevent morbidity and mortality related to the hypertensive state. Cardiovascul …
  • Thiazide Diuretics in the Treatment of Hypertension: An Update
    A Salvetti et al. J Am Soc Nephrol 17 (4 Suppl 2), S25-9. PMID 16565243. - Review
    Thiazide diuretics were the first tolerated efficient antihypertensive drugs that significantly reduced cardiovascular morbidity and mortality in placebo-controlled clini …
See all similar articles

Cited by 17 PubMed Central articles

See all "Cited by" articles

MeSH terms


LinkOut - more resources